$ZYME stock has now risen 7% today, according to our price data from Polygon. There has been approximately $12,731,309 of trading volume.
Here is what we see in our data on $ZYME (you can track the company live on Quiver's $ZYME stock page):$ZYME Insider Trading Activity
$ZYME insiders have traded $ZYME stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ZYME stock by insiders over the last 6 months:
- CAPITAL, LLC ECOR1 has made 4 purchases buying 184,134 shares for an estimated $2,091,993 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ZYME Hedge Fund Activity
We have seen 89 institutional investors add shares of $ZYME stock to their portfolio, and 84 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECOR1 CAPITAL, LLC added 5,710,840 shares (+33.1%) to their portfolio in Q2 2025, for an estimated $71,671,042
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,420,432 shares (-36.6%) from their portfolio in Q2 2025, for an estimated $17,826,421
- ASSENAGON ASSET MANAGEMENT S.A. added 833,994 shares (+169.2%) to their portfolio in Q3 2025, for an estimated $14,244,617
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 766,944 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $9,625,147
- VANGUARD GROUP INC added 697,652 shares (+39.5%) to their portfolio in Q2 2025, for an estimated $8,755,532
- VESTAL POINT CAPITAL, LP added 650,000 shares (+130.0%) to their portfolio in Q2 2025, for an estimated $8,157,500
- REDMILE GROUP, LLC removed 638,318 shares (-13.3%) from their portfolio in Q2 2025, for an estimated $8,010,890
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ZYME Analyst Ratings
Wall Street analysts have issued reports on $ZYME in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 10/10/2025
- Citigroup issued a "Buy" rating on 08/11/2025
- TD Securities issued a "Buy" rating on 05/20/2025
To track analyst ratings and price targets for $ZYME, check out Quiver Quantitative's $ZYME forecast page.
$ZYME Price Targets
Multiple analysts have issued price targets for $ZYME recently. We have seen 3 analysts offer price targets for $ZYME in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- Mayank Mamtani from B. Riley Securities set a target price of $30.0 on 10/10/2025
- Yigal Nochomovitz from Citigroup set a target price of $22.0 on 08/11/2025
- Robert Burns from HC Wainwright & Co. set a target price of $13.0 on 07/03/2025
You can track data on $ZYME on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
